Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic d-Peptide for Dual-Targeting Therapy of Lung Cancer
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Highly Potent, Selective, Biostable, and Cell-Permeable Cyclic d-Peptide for Dual-Targeting Therapy of Lung Cancer
Authors
Keywords
-
Journal
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
Volume 144, Issue 16, Pages 7117-7128
Publisher
American Chemical Society (ACS)
Online
2022-04-14
DOI
10.1021/jacs.1c12075
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Cancer Statistics, 2021
- (2021) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A Novel D Peptide Identified by Mirror‐image Phage Display Blocks TIGIT/PVR for Cancer Immunotherapy
- (2020) Xiuman Zhou et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Discovery of potent thrombin inhibitors from a protease-focused DNA-encoded chemical library
- (2020) Surendra Dawadi et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Pulmonary toxicity of systemic lung cancer therapy
- (2020) Kathryn Long et al. RESPIROLOGY
- Discovery of gramicidin A analogues with altered activities by multidimensional screening of a one-bead-one-compound library
- (2020) Yuri Takada et al. Nature Communications
- BI-3406, a potent and selective SOS1::KRAS interaction inhibitor, is effective in KRAS-driven cancers through combined MEK inhibition
- (2020) Marco H Hofmann et al. Cancer Discovery
- GTP-State-Selective Cyclic Peptide Ligands of K-Ras(G12D) Block Its Interaction with Raf
- (2020) Ziyang Zhang et al. ACS Central Science
- Understanding Cell Penetration of Cyclic Peptides
- (2019) Patrick G. Dougherty et al. CHEMICAL REVIEWS
- Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy
- (2019) Ke Xu et al. Molecular Cancer
- Impact of KRAS mutation subtype and concurrent pathogenic mutations on non-small cell lung cancer outcomes
- (2019) Jacqueline V. Aredo et al. LUNG CANCER
- A Redox‐Triggered Bispecific Supramolecular Nanomedicine Based on Peptide Self‐Assembly for High‐Efficacy and Low‐Toxic Cancer Therapy
- (2019) Da‐Song Yang et al. ADVANCED FUNCTIONAL MATERIALS
- Discovery of a Potent GLUT Inhibitor from a Library of Rapafucins by Using 3D Microarrays
- (2019) Zufeng Guo et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Thymopentin-loaded phospholipid-based phase separation gel with long-lasting immunomodulatory effects: in vitro and in vivo studies
- (2018) Ting Zhang et al. ACTA PHARMACOLOGICA SINICA
- Anticancer Supramolecular Hydrogel of D/L-Peptide with Enhanced Stability and Bioactivity
- (2018) Chunhua Ren et al. Journal of Biomedical Nanotechnology
- A printable hydrogel microarray for drug screening avoids false positives associated with promiscuous aggregating inhibitors
- (2018) Rabia Mateen et al. Nature Communications
- NRP1-positive lung cancer cells possess tumor-initiating properties
- (2017) Luis Jimenez-Hernandez et al. ONCOLOGY REPORTS
- In-Bead Screening of Hydroxamic Acids for the Identification of HDAC Inhibitors
- (2016) Katrine Qvortrup et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- A Cyclized Helix-Loop-Helix Peptide as a Molecular Scaffold for the Design of Inhibitors of Intracellular Protein-Protein Interactions by Epitope and Arginine Grafting
- (2016) Daisuke Fujiwara et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- D-Peptides as Recognition Molecules and Therapeutic Agents
- (2016) Min Liu et al. CHEMICAL RECORD
- DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors
- (2016) Philip A. Harris et al. JOURNAL OF MEDICINAL CHEMISTRY
- Screening of Pre-miRNA-155 Binding Peptides for Apoptosis Inducing Activity Using Peptide Microarrays
- (2016) Jaeyoung Pai et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Computational protein–ligand docking and virtual drug screening with the AutoDock suite
- (2016) Stefano Forli et al. Nature Protocols
- AD-Peptide Ligand of Nicotine Acetylcholine Receptors for Brain-Targeted Drug Delivery
- (2015) Xiaoli Wei et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Blocking of the PD-1/PD-L1 Interaction by aD-Peptide Antagonist for Cancer Immunotherapy
- (2015) Hao-Nan Chang et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Inhibition of Ras Signaling by Blocking Ras-Effector Interactions with Cyclic Peptides
- (2015) Punit Upadhyaya et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Therapeutic uses of somatostatin and its analogues: Current view and potential applications
- (2015) Uma Rai et al. PHARMACOLOGY & THERAPEUTICS
- Direct inhibition of oncogenic KRAS by hydrocarbon-stapled SOS1 helices
- (2015) Elizaveta S. Leshchiner et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Constraining Cyclic Peptides To Mimic Protein Structure Motifs
- (2014) Timothy A. Hill et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Retro-Inverso CendR Peptide-Mediated Polyethyleneimine for Intracranial Glioblastoma-Targeting Gene Therapy
- (2014) Jing Wang et al. BIOCONJUGATE CHEMISTRY
- Dragging Ras Back in the Ring
- (2014) Andrew G. Stephen et al. CANCER CELL
- Small-molecule modulation of Ras signaling
- (2014) Jochen Spiegel et al. Nature Chemical Biology
- Drugging the undruggable RAS: Mission Possible?
- (2014) Adrienne D. Cox et al. NATURE REVIEWS DRUG DISCOVERY
- An endocytosis pathway initiated through neuropilin-1 and regulated by nutrient availability
- (2014) Hong-Bo Pang et al. Nature Communications
- Screening Bicyclic Peptide Libraries for Protein–Protein Interaction Inhibitors: Discovery of a Tumor Necrosis Factor-α Antagonist
- (2013) Wenlong Lian et al. JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
- Discovery of Small Molecules that Bind to K-Ras and Inhibit Sos-Mediated Activation
- (2012) Qi Sun et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Ras inhibition via direct Ras binding—is there a path forward?
- (2012) Weiru Wang et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- KRAS mutations and resistance to EGFR-TKIs treatment in patients with non-small cell lung cancer: A meta-analysis of 22 studies
- (2009) Chen Mao et al. LUNG CANCER
- C-end rule peptides mediate neuropilin-1-dependent cell, vascular, and tissue penetration
- (2009) T. Teesalu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started